Delivery Order SPE2DB20D2104-SPE2DB25FMZEA
- Not listed
- The Defense Logistics Agency awarded a $4,920.22 delivery order to AmerisourceBergen Drug Corp for Cyanocobalamin 500 MCG Sprays, with an ultimate completion date of August 21, 2025. The contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded through the federal procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,604.33 to AmerisourceBergen Drug Corp for Cyanocobalamin 500 MCG sprays, with an ultimate completion date of July 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,469.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Cyanocobalamin 500 MCG sprays, with an ultimate completion date of April 28, 2025. This non-set-aside competitive award was issued on April 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Cyanocobalamin 500 MCG Sprays with a ceiling value of $4,926.27. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,265.55 for Cyanocobalamin 500 MCG Sprays, with an ultimate completion date of September 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,117.72 to AmerisourceBergen Drug Corp for Cyanocobalamin 500 mcg sprays. This is a firm fixed-price, competitively awarded contract with no set-aside designation, issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,889.29 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Cyanocobalamin 500 MCG Sprays, with an ultimate completion date of September 12, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,522.92 for Cyanocobalamin 500 MCG sprays on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,271.26 firm fixed-price contract is for the supply of 4567089899 CYANOCOBALAMIN 500 MCG SPRAYS, with a period of performance through January 30, 2025. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), has established itself as a key vendor for federal healthcare programs, particularly within...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $21,777.56, is for the delivery of Cyanocobalamin 500 MCG sprays. This is a firm fixed-price delivery order contract with a completion date of March 13, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMZEADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,810.21 to AmerisourceBergen Drug Corp for the supply of Cyanocobalamin 500 mcg sprays. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 2, 2025, and was awarded on August 29, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 million comprehensive pharmaceutical support vehicle that runs through December 2026 and serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, is well-positioned to fulfill this requirement as a critical federal medical procurement vendor. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The DLA utilizes the IDC structure to enable flexible procurement of essential pharmaceutical commodities to support military and veteran healthcare systems, and AmerisourceBergen's status as a prime vendor under this vehicle reflects its consistent ability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 8/29/25 |